Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments
Year: 2018
Type: review
Abstract: gene which encodes Rab escort protein 1 (REP1), an ubiquitously expressed protein involved in intracellular trafficking and prenylation activity. The exact site of pathogenesis remains unclear but results in degeneration of the photoreceptors, retinal pigment epithelium and choroid. Animal and stem cell models have been used to study the molecular defects in choroideremia and test effectiveness of treatment interventions. Natural history studies of choroideremia have provided additional insight into the clinical phenotype of the condition and prepared the way for clinical trials aiming to investigate the safety and efficacy of suitable therapies. In this review, we provide a summary of the current knowledge on the genetics, pathophysiology, clinical features and therapeutic strategies that might become available for choroideremia in the future, including gene therapy, stem cell treatment and small-molecule drugs with nonsense suppression action.
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: choroideremia, Rab escort protein 1, REP1, gene therapy, stem cell therapy, nonsense suppression, photoreceptor degeneration, retinal pigment epithelium degeneration, choroidal degeneration, pathophysiology, natural history (disease), clinical phenotype, small molecule drugs, animal models
Open Access status: gold
Estimated APC paid: $2,650
OpenAlex ID: W2907978387
